New HIV Treatment Would Only Require Monthly Injection

April 30, 2019
Viiv Healthcare, a pharmaceutical company established ten years ago by GlaxoSmithKline and Pfizer, is dedicated solely to developing HIV treatments. The company has submitted its new monthly, injectable medication for FDA approval. Joining us on this development was Dr. John Pottage, Chief Scientific and Medical Officer at Viiv.